Sieber Karsten B, Batorsky Anna, Siebenthall Kyle, Hudkins Kelly L, Vierstra Jeff D, Sullivan Shawn, Sur Aakash, McNulty Michelle, Sandstrom Richard, Reynolds Alex, Bates Daniel, Diegel Morgan, Dunn Douglass, Nelson Jemma, Buckley Michael, Kaul Rajinder, Sampson Matthew G, Himmelfarb Jonathan, Alpers Charles E, Waterworth Dawn, Akilesh Shreeram
GlaxoSmithKline, LLC, Collegeville, Pennsylvania.
Altius Institute for Biomedical Sciences, Seattle, Washington.
J Am Soc Nephrol. 2019 Mar;30(3):421-441. doi: 10.1681/ASN.2018030309. Epub 2019 Feb 13.
Linking genetic risk loci identified by genome-wide association studies (GWAS) to their causal genes remains a major challenge. Disease-associated genetic variants are concentrated in regions containing regulatory DNA elements, such as promoters and enhancers. Although researchers have previously published DNA maps of these regulatory regions for kidney tubule cells and glomerular endothelial cells, maps for podocytes and mesangial cells have not been available.
We generated regulatory DNA maps (DNase-seq) and paired gene expression profiles (RNA-seq) from primary outgrowth cultures of human glomeruli that were composed mainly of podocytes and mesangial cells. We generated similar datasets from renal cortex cultures, to compare with those of the glomerular cultures. Because regulatory DNA elements can act on target genes across large genomic distances, we also generated a chromatin conformation map from freshly isolated human glomeruli.
We identified thousands of unique regulatory DNA elements, many located close to transcription factor genes, which the glomerular and cortex samples expressed at different levels. We found that genetic variants associated with kidney diseases (GWAS) and kidney expression quantitative trait loci were enriched in regulatory DNA regions. By combining GWAS, epigenomic, and chromatin conformation data, we functionally annotated 46 kidney disease genes.
We demonstrate a powerful approach to functionally connect kidney disease-/trait-associated loci to their target genes by leveraging unique regulatory DNA maps and integrated epigenomic and genetic analysis. This process can be applied to other kidney cell types and will enhance our understanding of genome regulation and its effects on gene expression in kidney disease.
将全基因组关联研究(GWAS)确定的遗传风险位点与其因果基因联系起来仍然是一项重大挑战。与疾病相关的基因变异集中在包含调控DNA元件的区域,如启动子和增强子。尽管研究人员此前已发表了肾小管细胞和肾小球内皮细胞这些调控区域的DNA图谱,但足细胞和系膜细胞的图谱尚未可得。
我们从主要由足细胞和系膜细胞组成的人肾小球原代生长培养物中生成了调控DNA图谱(DNase-seq)和配对基因表达谱(RNA-seq)。我们从肾皮质培养物中生成了类似的数据集,以便与肾小球培养物的数据集进行比较。由于调控DNA元件可在较大基因组距离上作用于靶基因,我们还从新鲜分离的人肾小球中生成了染色质构象图谱。
我们鉴定出数千个独特的调控DNA元件,其中许多位于转录因子基因附近,肾小球和皮质样本以不同水平表达这些元件。我们发现与肾脏疾病(GWAS)相关的基因变异和肾脏表达数量性状位点在调控DNA区域中富集。通过整合GWAS、表观基因组和染色质构象数据,我们对46个肾脏疾病基因进行了功能注释。
我们展示了一种强大的方法,通过利用独特的调控DNA图谱以及整合表观基因组和遗传分析,在功能上将肾脏疾病/性状相关位点与其靶基因联系起来。这一过程可应用于其他肾脏细胞类型,并将增进我们对基因组调控及其对肾脏疾病中基因表达影响的理解。